GSK Investigational Site
Barrie, Ontario L4M 7G1
0 studies enrolling now · 14 studies all time
What they study most
Alzheimer's Disease, Arthritis, Rheumatoid, Dermatitis, Atopic, Diabetes Mellitus, Type 2, Hepatitis C, Chronic, Incontinence, Urinary and Urinary Bladder, Overactive, Neoplasms, Breast, Neoplasms, Prostate, Overactive Bladder, Prostatic Hyperplasia
Studies at this site
- Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. — Stopped early
- A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis — Stopped early
- Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors — Completed
- Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
- Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
- Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
- Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy — Completed
- A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder — Completed
- Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men — Completed
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease — Completed